Antonello Quadri

817 total citations
12 papers, 557 citations indexed

About

Antonello Quadri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Antonello Quadri has authored 12 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Antonello Quadri's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Antonello Quadri is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Antonello Quadri collaborates with scholars based in Italy, Netherlands and India. Antonello Quadri's co-authors include Roberto Labianca, Giordano Beretta, Laura Milesi, Stefania Mosconi, M.A. Pessi, Tiziana Prochilo, J. Wils, Gemma Gatta, Filippo de Braud and F. Merlin and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Antonello Quadri

12 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonello Quadri Italy 7 325 170 151 115 93 12 557
Laura Milesi Italy 9 256 0.8× 95 0.6× 132 0.9× 89 0.8× 56 0.6× 16 475
Tiziana Prochilo Italy 14 516 1.6× 189 1.1× 176 1.2× 245 2.1× 105 1.1× 41 803
Kateřina Kopečková Czechia 13 220 0.7× 137 0.8× 152 1.0× 100 0.9× 106 1.1× 61 477
Michail Nikolaou Greece 13 318 1.0× 113 0.7× 360 2.4× 198 1.7× 56 0.6× 41 871
Sekio Nagayama Japan 14 481 1.5× 197 1.2× 275 1.8× 59 0.5× 42 0.5× 38 830
Denghai Mi China 12 145 0.4× 151 0.9× 174 1.2× 94 0.8× 42 0.5× 35 501
F. Merlin Italy 8 167 0.5× 72 0.4× 112 0.7× 70 0.6× 48 0.5× 18 504
Antonin Schmitt France 15 274 0.8× 118 0.7× 208 1.4× 52 0.5× 57 0.6× 48 557
K. Weigang-Köhler Germany 11 401 1.2× 222 1.3× 113 0.7× 112 1.0× 32 0.3× 13 555
Rui Bras-Gonçalves France 11 237 0.7× 103 0.6× 206 1.4× 86 0.7× 55 0.6× 12 493

Countries citing papers authored by Antonello Quadri

Since Specialization
Citations

This map shows the geographic impact of Antonello Quadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonello Quadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonello Quadri more than expected).

Fields of papers citing papers by Antonello Quadri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonello Quadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonello Quadri. The network helps show where Antonello Quadri may publish in the future.

Co-authorship network of co-authors of Antonello Quadri

This figure shows the co-authorship network connecting the top 25 collaborators of Antonello Quadri. A scholar is included among the top collaborators of Antonello Quadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonello Quadri. Antonello Quadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
D’Alessio, A., et al.. (2016). Cutaneous Toxicity from Epidermal Growth Factor Receptor Inhibitors: Would a Subcutaneous Desensitization be Helpful? Case Report. Tumori Journal. 102(2_suppl). S65–S68. 2 indexed citations
2.
Poli, G., Anna Bettini, Claudia Bianchi, et al.. (2012). Radioimmunotherapy with 131I-L19SIP (Radretumab) in metastatic solid tumors: Preliminary results. 53. 498–498. 3 indexed citations
3.
Labianca, Roberto, Giordano Beretta, Laura Milesi, et al.. (2010). Colon cancer. Critical Reviews in Oncology/Hematology. 74(2). 106–133. 308 indexed citations
4.
5.
Scartozzi, Mario, Italo Bearzi, Alessandra Mandolesi, et al.. (2009). Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.. PubMed. 31(6). 417–23. 3 indexed citations
6.
Labianca, Roberto, et al.. (2008). Perioperative or postoperative therapy for resectable gastric cancer?. Annals of Oncology. 19. v99–v102. 2 indexed citations
7.
Labianca, Roberto, Laura Milesi, Stefania Mosconi, et al.. (2007). The role of adjuvant chemotherapy in colon cancer. Surgical Oncology. 16. 93–96. 10 indexed citations
8.
Scartozzi, Mario, Italo Bearzi, Chiara Pierantoni, et al.. (2007). Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy. Journal of Clinical Oncology. 25(25). 3930–3935. 103 indexed citations
9.
Mandalà, Mario, Stefania Mosconi, Antonello Quadri, Laura Milesi, & Roberto Labianca. (2007). Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer. Expert Review of Anticancer Therapy. 7(6). 887–897. 6 indexed citations
10.
Dranitsaris, George, et al.. (2001). A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy. PharmacoEconomics. 19(9). 955–967. 16 indexed citations
11.
Beretta, Giordano, et al.. (2000). Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer. British Journal of Cancer. 83(5). 573–576. 41 indexed citations
12.
Schena, M, et al.. (1985). [Alpha 1-antitrypsin as a tumor marker].. PubMed. 21(1). 87–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Milesi Breakdown of academic impact, for papers by Tiziana Prochilo Breakdown of academic impact, for papers by Kateřina Kopečková Breakdown of academic impact, for papers by Michail Nikolaou Breakdown of academic impact, for papers by Sekio Nagayama Breakdown of academic impact, for papers by Denghai Mi Breakdown of academic impact, for papers by F. Merlin Breakdown of academic impact, for papers by Antonin Schmitt Breakdown of academic impact, for papers by K. Weigang-Köhler Breakdown of academic impact, for papers by Rui Bras-Gonçalves
Rankless by CCL
2026